Filed: 5/15/2025ACC: 0001104659-25-048878
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 34 equity positions with a total reported market value of $86.23M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
34
Positions
$86.23M
Total AUM (reported)
11.68M
Total Shares
Allocation by class
COM$52.55M60.9%
COM NEW$10.31M12.0%
COM PAR $.01$8.09M9.4%
SPONSORED ADR$7.79M9.0%
ORDINARY SHARES$2.38M2.8%
CL A ORD SHS$2.12M2.5%
SPON ADS$1.78M2.1%
Portfolio Concentration
Top 3$23.53M27.3%
4–10$32.13M37.3%
11–25$27.23M31.6%
Rest$3.35M3.9%
Top 3 weight
27.3%
Top 10 weight
64.5%
Voting Authority Distribution
Total shares with voting rights: 11.68M
Sole
Full voting authority
11.68M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole34
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings34
Rows:
OCULAR THERAPEUTIX INC
SOLEShares1.22M
TypeSH
Market value$8.94M
10.37%
Sole
1.22M
Shared
0.00
None
0.00
INSMED INC
SOLEShares106.07K
TypeSH
Market value$8.09M
9.38%
Sole
106.07K
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares426.88K
TypeSH
Market value$6.49M
7.53%
Sole
426.88K
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares3.41M
TypeSH
Market value$6.07M
7.04%
Sole
3.41M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares265.27K
TypeSH
Market value$5.22M
6.05%
Sole
265.27K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares785.96K
TypeSH
Market value$4.94M
5.73%
Sole
785.96K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares67.14K
TypeSH
Market value$4.80M
5.56%
Sole
67.14K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares7.02K
TypeSH
Market value$4.16M
4.82%
Sole
7.02K
Shared
0.00
None
0.00
ASCENDIS PHA-ADR
SOLEShares23.34K
TypeSH
Market value$3.64M
4.22%
Sole
23.34K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares87.14K
TypeSH
Market value$3.30M
3.83%
Sole
87.14K
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares125.71K
TypeSH
Market value$2.71M
3.14%
Sole
125.71K
Shared
0.00
None
0.00
OCULIS HOLDING AG
SOLEShares125K
TypeSH
Market value$2.38M
2.76%
Sole
125K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares66.66K
TypeSH
Market value$2.36M
2.73%
Sole
66.66K
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares153.48K
TypeSH
Market value$2.26M
2.63%
Sole
153.48K
Shared
0.00
None
0.00
BRIGHT MINDS BIOSCIENCES INC
SOLEShares59.75K
TypeSH
Market value$2.16M
2.50%
Sole
59.75K
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
SOLEShares187.26K
TypeSH
Market value$2.12M
2.45%
Sole
187.26K
Shared
0.00
None
0.00
MERCK & CO
SOLEShares22.99K
TypeSH
Market value$2.06M
2.39%
Sole
22.99K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares170K
TypeSH
Market value$1.98M
2.30%
Sole
170K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares85.45K
TypeSH
Market value$1.88M
2.18%
Sole
85.45K
Shared
0.00
None
0.00
MEREO BIOPHARMA GROUP PL-ADR
SOLEShares791.82K
TypeSH
Market value$1.78M
2.07%
Sole
791.82K
Shared
0.00
None
0.00
UNICYCIVE THERAPEUTICS INC
SOLEShares2.35M
TypeSH
Market value$1.35M
1.57%
Sole
2.35M
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares9.57K
TypeSH
Market value$1.19M
1.38%
Sole
9.57K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares176K
TypeSH
Market value$1.06M
1.23%
Sole
176K
Shared
0.00
None
0.00
GILEAD SCIENCES INC
SOLEShares9.30K
TypeSH
Market value$1.04M
1.21%
Sole
9.30K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares325.55K
TypeSH
Market value$898.5K
1.04%
Sole
325.55K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
OCULAR THERAPEUTIX INCSOLE | COM | 1.22M | SH | $8.94M 10.37% | 1.22M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 106.07K | SH | $8.09M 9.38% | 106.07K | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COM | 426.88K | SH | $6.49M 7.53% | 426.88K | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 3.41M | SH | $6.07M 7.04% | 3.41M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 265.27K | SH | $5.22M 6.05% | 265.27K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 785.96K | SH | $4.94M 5.73% | 785.96K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 67.14K | SH | $4.80M 5.56% | 67.14K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 7.02K | SH | $4.16M 4.82% | 7.02K | 0.00 | 0.00 |
ASCENDIS PHA-ADRSOLE | SPONSORED ADR | 23.34K | SH | $3.64M 4.22% | 23.34K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM | 87.14K | SH | $3.30M 3.83% | 87.14K | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM NEW | 125.71K | SH | $2.71M 3.14% | 125.71K | 0.00 | 0.00 |
OCULIS HOLDING AGSOLE | ORDINARY SHARES | 125K | SH | $2.38M 2.76% | 125K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 66.66K | SH | $2.36M 2.73% | 66.66K | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 153.48K | SH | $2.26M 2.63% | 153.48K | 0.00 | 0.00 |
BRIGHT MINDS BIOSCIENCES INCSOLE | COM NEW | 59.75K | SH | $2.16M 2.50% | 59.75K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IISOLE | CL A ORD SHS | 187.26K | SH | $2.12M 2.45% | 187.26K | 0.00 | 0.00 |
MERCK & COSOLE | COM | 22.99K | SH | $2.06M 2.39% | 22.99K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 170K | SH | $1.98M 2.30% | 170K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 85.45K | SH | $1.88M 2.18% | 85.45K | 0.00 | 0.00 |
MEREO BIOPHARMA GROUP PL-ADRSOLE | SPON ADS | 791.82K | SH | $1.78M 2.07% | 791.82K | 0.00 | 0.00 |
UNICYCIVE THERAPEUTICS INCSOLE | COM | 2.35M | SH | $1.35M 1.57% | 2.35M | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 9.57K | SH | $1.19M 1.38% | 9.57K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 176K | SH | $1.06M 1.23% | 176K | 0.00 | 0.00 |
GILEAD SCIENCES INCSOLE | COM | 9.30K | SH | $1.04M 1.21% | 9.30K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 325.55K | SH | $898.5K 1.04% | 325.55K | 0.00 | 0.00 |
Page 1 of 2